We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,949

SPC reference to the CJEU and combination drug cross-undertaking granted
  • McDermott Will & Emery
  • European Union, United Kingdom
  • November 7 2013

In Actavis Group PTC EHF & Anor v Boehringer Ingelheim Pharma GmbH & Co, KG 2013 EWHC 2927 (Pat), the High Court of England and Wales agreed to

The Court of Appeal applies the CJEU SPC decision in Medeva
  • Herbert Smith Freehills LLP
  • European Union
  • May 4 2012

Following its reference to the Court of Justice of the EU (CJEU) in Medeva on the meaning of Art 3 of the SPC Regulation, the Court of Appeal has applied the CJEU's judgment to the facts of the case (Medeva BV v . Comptroller General of Patents 2012 EWCA 523

Life sciences & law current issues 201213
  • Gowling Lafleur Henderson LLP
  • Canada, European Union, USA
  • June 18 2012

Each stage of the life cycle of a company or a product presents challenges that demand the expertise and resources of a strong legal partner

Opinion of Advocate General Trstenjak
  • Wragge Lawrence Graham & Co LLP
  • European Union
  • May 10 2012

Last week, Advocate General Trstenjak gave her opinion on the latest supplementary protection certificates (SPC) case to reach the Court of Justice of the European Communities (CJEU

Intellectual Property & Technology, Media and Telecommunications newsletter (number 32)
  • Herbert Smith Freehills LLP
  • European Union, USA
  • May 27 2013

In Microsoft Corporation v Motorola Inc. the Washington District Court recently issued its findings (25 April 2013) setting out a list of "Economic

Two more SPC questions referred to the EU Court of Justice
  • Mewburn Ellis LLP
  • European Union, United Kingdom
  • September 28 2012

In Actavis Group PTC EHF & another v Sanofi Pharma Bristol-Myers Squibb the UK High Court has referred two further questions relating to the scope of Supplementary Protection Certificates (SPCs) for pharmaceutical products to the Court of Justice of the European Union (CJEU

Apple vs Samsung: the long war
  • William Fry
  • European Union, USA
  • December 21 2012

Apple has lost its appeal to ban the sale of 26 patent infringing Samsung devices in the US after it failed to establish that these Samsung

The relevance of EPO decisions to Singapore
  • Bird & Bird ATMD LLP
  • European Union, Singapore
  • October 26 2012

Main-Line Corporate Holdings Ltd (Main-Line) is the owner of a patented method and system registered in Singapore on 30 June 2003, that automatically determines the operating currency in which to process a transaction for a credit card, charge card or debit card at the point of sale between a merchant and the cardholder, without the need for any manual selection or intervention by the merchant andor the cardholder to identify the card’s currency (the Patent

Other news - latest on unitary patents
  • Fieldfisher
  • European Union
  • October 16 2012

It is also proposed that parties will have to apply specifically for "discovery" by showing that the other party is likely to have documents that are significant to live issues in the dispute

Virgin Atlantic Airways v Contour Aerospace and others: which country did you say?
  • Fieldfisher
  • European Union, United Kingdom
  • October 16 2012

The High Court has recently held that it is not entitled to review administrative decisions of the EPO declining to give declaratory relief to Contour Aerospace (formerly Premium Aircrafts Interiors UK